These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16597829)

  • 1. Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study.
    Rajan RS; Li T; Aras M; Sloey C; Sutherland W; Arai H; Briddell R; Kinstler O; Lueras AM; Zhang Y; Yeghnazar H; Treuheit M; Brems DN
    Protein Sci; 2006 May; 15(5):1063-75. PubMed ID: 16597829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T
    Robinson MJ; Matejtschuk P; Bristow AF; Dalby PA
    Mol Pharm; 2018 Jan; 15(1):256-267. PubMed ID: 29141152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conjugation with polyethylene glycol].
    Puchkov IA; Kononova NV; Bobruskin AI; Bairamashvili DI; Mart'ianov VA; Shuster AM
    Bioorg Khim; 2012; 38(5):545-54. PubMed ID: 23342488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor (GCSF) fused with Fc Domain produced from E. coli is less effective than Polyethylene Glycol-conjugated GCSF.
    Do BH; Kang HJ; Song JA; Nguyen MT; Park S; Yoo J; Nguyen AN; Kwon GG; Jang J; Jang M; Lee S; So S; Sim S; Lee KJ; Osborn MJ; Choe H
    Sci Rep; 2017 Jul; 7(1):6480. PubMed ID: 28744022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored PEG for rh-G-CSF analogue site-specific conjugation.
    Salmaso S; Bersani S; Scomparin A; Mastrotto F; Scherpfer R; Tonon G; Caliceti P
    Bioconjug Chem; 2009 Jun; 20(6):1179-85. PubMed ID: 19469471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential phenotype of immune cells in blood and milk following pegylated granulocyte colony-stimulating factor therapy during a chronic Staphylococcus aureus infection in lactating Holsteins.
    Putz EJ; Eder JM; Reinhardt TA; Sacco RE; Casas E; Lippolis JD
    J Dairy Sci; 2019 Oct; 102(10):9268-9284. PubMed ID: 31400902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pegylated granulocyte colony-stimulating factor treatment prior to experimental mastitis in lactating Holsteins.
    Powell EJ; Reinhardt TA; Casas E; Lippolis JD
    J Dairy Sci; 2018 Sep; 101(9):8182-8193. PubMed ID: 29885891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
    Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
    Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between native-state solubility and non-native aggregation of recombinant human granulocyte colony stimulating factor: practical implications for protein therapeutic development.
    Banks DD; Zhang J; Siska CC
    Mol Pharm; 2014 Oct; 11(10):3431-42. PubMed ID: 25144791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.
    Reddy P; Kanan S; Cowan A; Warren H; Till B; Shadman M; Cassaday R; Press O; Shustov A; Gopal A; Smith SD
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e87-e90. PubMed ID: 28870643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin in aqueous solutions.
    Taluja A; Bae YH
    Pharm Res; 2007 Aug; 24(8):1517-26. PubMed ID: 17385016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of affinity sensor response kinetics towards dimeric ligands linked with spacers of different rigidity: Immobilized recombinant granulocyte colony-stimulating factor based synthetic receptor binding with genetically engineered dimeric analyte derivatives.
    Plikusiene I; Balevicius Z; Ramanaviciene A; Talbot J; Mickiene G; Balevicius S; Stirke A; Tereshchenko A; Tamosaitis L; Zvirblis G; Ramanavicius A
    Biosens Bioelectron; 2020 May; 156():112112. PubMed ID: 32174551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of a 2:2 complex of granulocyte-colony stimulating factor (GCSF) with the ligand-binding region of the GCSF receptor.
    Honjo E; Tamada T; Maeda Y; Koshiba T; Matsukura Y; Okamoto T; Ishibashi M; Tokunaga M; Kuroki R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Aug; 61(Pt 8):788-90. PubMed ID: 16511159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of polyethylene glycol-induced precipitation as predictive tool for protein solubility during formulation development.
    Hofmann M; Winzer M; Weber C; Gieseler H
    J Pharm Pharmacol; 2018 May; 70(5):648-654. PubMed ID: 28106257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex.
    Tamada T; Honjo E; Maeda Y; Okamoto T; Ishibashi M; Tokunaga M; Kuroki R
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3135-40. PubMed ID: 16492764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of human GCSF serum half-life by the fusion of albumin binding domain.
    Nikravesh FY; Shirkhani S; Bayat E; Talebkhan Y; Mirabzadeh E; Sabzalinejad M; Aliabadi HAM; Nematollahi L; Ardakani YH; Sardari S
    Sci Rep; 2022 Jan; 12(1):667. PubMed ID: 35027593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of PEGylated GCSF from Non-classical Inclusion Bodies Expressed in
    Trinh NTM; Thuoc TL; Thao DTP
    Avicenna J Med Biotechnol; 2021; 13(4):192-200. PubMed ID: 34900145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse relationship of protein concentration and aggregation.
    Treuheit MJ; Kosky AA; Brems DN
    Pharm Res; 2002 Apr; 19(4):511-6. PubMed ID: 12033388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the pH-dependent aggregation mechanisms of GCSF using low resolution protein characterization techniques and advanced molecular dynamics simulations.
    Ko SK; Berner C; Kulakova A; Schneider M; Antes I; Winter G; Harris P; Peters GHJ
    Comput Struct Biotechnol J; 2022; 20():1439-1455. PubMed ID: 35386098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective domain stabilization as a strategy to reduce human serum albumin-human granulocyte colony stimulating factor aggregation rate.
    Cordes AA; Carpenter JF; Randolph TW
    J Pharm Sci; 2012 Jun; 101(6):2009-16. PubMed ID: 22422106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.